GeneDx (NASDAQ: WGS) shares fell Wednesday. The company, a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through ...

GeneDx , a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through understanding gene-disease relationships, ...

BTIG Life Sciences and Diagnostic Tools Analyst Massaro holds group dinner meeting with CEO Stueland and CFO Feeley on January 13 at 10:30 am.

CEO Katherine Stueland sold 18,006 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The ...

Inari Medical stock skyrocketed Tuesday after Stryker agreed to buy the medical devices company for $4.9 billion.Please watch ...

TD Cowen raised the firm’s price target on GeneDx (WGS) to $118 from $75 and keeps a Buy rating on the shares. The firm reviewed its financial ...

GeneDx Holdings (WGS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...

Shares of the IBD 50's GeneDx surged Monday after the Food and Drug Administration issued guidance about using AI to develop ...

Shares of IBD 50's GeneDx surged Monday after the Food and Drug Administration issued guidance about using AI to develop ...

Meta Platforms leads five stocks flashing entries as they rebound above key moving averages within consolidations.

NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year.

GeneDx has appointed Bryan Dechairo as chief operating officer, effective immediately. The role is newly created, said the Stamford, Conn.-based genetic testing company. Dechairo will manage product ...